title: Breakout II. Reimbursement concerns.
authors.forename: J E
authors.initials: JE
authors.lastname: Henney
authors.forename: T
authors.initials: T
authors.lastname: Greene
authors.forename: N
authors.initials: N
authors.lastname: Aronson
authors.forename: J E
authors.initials: JE
authors.lastname: Johnson
authors.forename: M
authors.initials: M
authors.lastname: McCabe
authors.forename: G P
authors.initials: GP
authors.lastname: Monaco
authors.forename: C A
authors.initials: CA
authors.lastname: Poulter
mesh_terms: D000570:American Cancer Society; D002986:Clinical Trials as Topic / Q000191:economics*; D015507:Drugs, Investigational / Q000627:therapeutic use; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics*; D010344:Patient Advocacy; D010353:Patient Education as Topic; D014481:United States
chemical_list: D015507:Drugs, Investigational